Evidence map›Paper›PMID 40934266›Full record

ArticlePloS one2025

The impact of evolving maternal antiretroviral therapy guidelines on vertical transmission of HIV in the Western Cape, South Africa.

Nisha Jacob, Emma Kalk, Alexa Heekes, Florence Phelanyane, Kim Anderson, Mary-Ann Davies, Brian Rice, Andrew Boulle

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nisha JacobSchool of Public Health, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-7028-5772
Emma KalkSchool of Public Health, University of Cape Town, Cape Town, South Africa.ORCID 0000-0001-7706-6866
Alexa HeekesSchool of Public Health, University of Cape Town, Cape Town, South Africa.ORCID 0000-0003-2430-5194
Florence PhelanyaneSchool of Public Health, University of Cape Town, Cape Town, South Africa.
Kim AndersonSchool of Public Health, University of Cape Town, Cape Town, South Africa.
Mary-Ann DaviesSchool of Public Health, University of Cape Town, Cape Town, South Africa.
Brian RiceSchool of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.
Andrew BoulleSchool of Public Health, University of Cape Town, Cape Town, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDespite universal HIV test-and-treat policy in South Africa, vertical transmission continues to occur. We evaluated the temporal effectiveness of vertical transmission prevention (VTP) over three maternal antiretroviral therapy (ART) policy periods (three-drug ART accessible to those with CD4 counts <200 cells/µl (January 2010 - March 2010); < 350 cells/µl (April 2010 - April 2013); and lifelong ART regardless of CD4 count (May 2013 - December 2020)) in Western Cape, South Africa using public sector routine individuated data.

methodsWe conducted a retrospective cohort study with child HIV infection as the primary outcome. The cohort of 842 641 pregnancies from 2010-2020, inclusive of child HIV exposure, maternal ART, and child outcomes, was enumerated using administrative, laboratory and pharmacy data. Multivariable logistic regression was used to explore associations with vertical transmission.

resultsThe proportion of pregnant women living with HIV (WLWH) initiating ART prior to pregnancy increased from 20.9% in 2010 to 71.1% in 2020. Of all pregnancies 17.1% (143 987/842 641) were HIV exposed and 16.3% (137 572/842 641) had a record of a child HIV outcome, of whom 3966 (2.9%) were HIV positive by 24 months. Among children with known maternal HIV exposure (143 987), 32.0% had unknown HIV status and 2.1% were diagnosed with HIV by study closure. In 2020, HIV status was ascertained in 87.2% (16 908/19 382) of children exposed to HIV. Children born in policy period 3 were less likely to have HIV than children born in policy period 2 (aOR 0.66; 95% CI 0.60-0.72), mediated through expanded ART access. Between 2017 and 2020, 16.5% of child HIV diagnoses were from pregnancies without maternal HIV exposure records. Young maternal age, no antenatal ART, previous tuberculosis and no records of antenatal visits were associated with vertical transmission in all periods.

conclusionsUsing routine data, we report an increase in WLWH initiating ART prior to pregnancy, and a decline in vertical transmission of HIV over three policy periods. Although HIV diagnosis amongst children exposed to HIV has reduced over time, the proportion of infections in children without established exposure emphasises the need to optimise VTP opportunities.

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsHIV InfectionsInfectious Disease Transmission, VerticalPregnancy Complications, InfectiousAdultCD4 Lymphocyte CountFemaleHumansInfantInfant, NewbornMalePregnancyRetrospective StudiesSouth AfricaYoung AdultAnti-HIV AgentsAnti-Retroviral Agents

Identifiers

PMID40934266
PMCPMC12425232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.